Adma Biologics

Ticker ADMA

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Ramsey, New Jersey

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of Primary Immune Deficiency Disease (PIDD) and certain infectious diseases.

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (208)

Adma Biologics reports have an aggregate usefulness score of 4.8 based on 208 reviews.

Adma Biologics

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Adma Biologics does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.